Get notified when KTTA files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsCritical incident detected
Existential event
Time-sensitive event — see the red-flag panel below for the source-quoted detail.
Red Flags Detected
- Going Concern (new) — The auditor's report includes an explanatory paragraph expressing substantial doubt about the company's ability to continue as a going concern.
- Reliance On Foreign Cros/cmos, Including Wuxi Apptec (new) — The company names WuXi AppTec and flags potential U.S. legislation (BIOSECURE bill) and trade restrictions that could disrupt supply or increase costs.
Pasithea Therapeutics files $2.08M at-the-market offering; auditor flags going concern doubt
Filed November 26, 2024 · ~1 min read
Key Changes
-
high
Pasithea Therapeutics may sell up to $2,076,000 of common stock in an at-the-market offering with H.C. Wainwright as sales agent.
The Offering verify on EDGAR → -
medium
The offering has no minimum amount; actual proceeds are uncertain and will be used for working capital and general corporate purposes.
Use of Proceeds verify on EDGAR → -
high
New investors face immediate dilution of about $3.28 per share based on the assumed offering price of $3.05.
Dilution verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SAR 10-Q) is open in full — no account needed.
Partner
Trade KTTA commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify